Increased thyroid cancer risk in acromegaly

Pituitary

Volumn 17, Issue 4, 2014, Pages 299-306

  Dagdelen, Selcuk ^a   Cinar, Nese ^a   Erbas, Tomris ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acromegaly; Cancer; GH; IGF 1; Thyroid

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ACROMEGALY; ADULT; AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CAUSE OF DEATH; COLON ADENOMA; COLON CANCER; COLON DIVERTICULOSIS; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HURTHLE CELL CANCER; INTRADUCTAL CARCINOMA; KIDNEY CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MELANOMA; METASTASIS; PAROTID GLAND CARCINOMA; PAROTID MUCOEPIDERMOID CARCINOMA; PREVALENCE; PRIORITY JOURNAL; RECTAL CARCINOID TUMOR; RECTUM TUMOR; RETROSPECTIVE STUDY; SEX DIFFERENCE; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; VATER PAPILLA TUMOR; AGED; COMPLICATION; METABOLISM; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS;

ACROMEGALY; ADULT; AGED; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS;

EID: 84904123999     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-013-0501-5     Document Type: Article

References (46)

1. Barzilay J, Heatley GJ, Cushing GW (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151(8):1629-1632
2. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J, The Pituitary Study Group (1998) Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol (Oxf) 49(4):441-445 (Pubitemid 28475335)
3. Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86(7):2935-2941 (Pubitemid 32673444)
4. Melmed S (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86(7):2929-2934
5. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? Rev Endocr Metab Disord 9(1):3339. doi:10.1007/s11154-007-9067-8
6. Renehan AG, Brennan BM (2008) Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):639-657. doi:10.1016/j.beem.2008.08. 011
7. Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R (1999) Insulin and IGF-I receptors signaling in protection from apoptosis. Horm Metab Res 31(2-3):80-89. doi:10.1055/s-2007-978703 (Pubitemid 29169480)
8. Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL, Pommier GJ (2000) Insulin like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 60(7):2007-2017 (Pubitemid 30207664)
9. Jenkins PJ (2006) Cancers associated with acromegaly. Neuroendocrinology 83(3-4):218-223. doi:10.1159/000095531
10. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83(8):2730-2734 (Pubitemid 28493768)
11. Bayram F, Gedik VT, Demir O, Kaya A, Gundogan K, Emral R, Ozturk A, Uysal AR, Corapcioglu D (2011) Epidemiologic survey: reference ranges of serum insulin-like growth factor 1 levels in Caucasian adult population with immunoradiometric assay. Endocrine 40(2):304-309. doi:10.1007/s12020-011-9476-z
12. Mustacchi P, Shimkin MB (1957) Occurrence of cancer in acromegaly and in hypopituitarism. Cancer 10(1):100-104
13. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13(5):395-400 (Pubitemid 34666594)
14. Higuchi Y, Saeki N, Iuchi T, Uchino Y, Tatsuno I, Uchida D, Tanaka T, Noguchi Y, Nakamura S, Yasuda T, Yamaura A, Sunami K, Oka Y, Uozumi A (2000) Incidence of malignant tumors in patients with acromegaly. Endocr J 47(Suppl):S57-S60 (Pubitemid 30243435)
15. Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Uum S, Rivera J, Caspar-Bell G, Serri O (2012) Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf). doi:10.1111/cen.12112
16. Bates AS, Van't Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81(3):1169-1172 (Pubitemid 26083989)
17. Eser S, Yakut C, Ozdemir R, Karakilinc H, Ozalan S, Marshall SF, Karaoglanoglu O, Anbarcioglu Z, Ucuncu N, Akin U, Ozen E, Ozgul N, Anton-Culver H, Tuncer M (2010) Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev 11(6):1731-1739
18. Gullu BE, Celik O, Gazioglu N, Kadioglu P (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13(3):242-248. doi:10.1007/s11102-010-0224-9
19. Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K (1988) Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab 67(5):973-978
20. Kasagi K, Shimatsu A, Miyamoto S, Misaki T, Sakahara H, Konishi J (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9(8):791-796 (Pubitemid 29409663)
21. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25(3):240-245 (Pubitemid 34295879)
22. Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46(5):545-549 (Pubitemid 27286926)
23. Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9(1):41-58. doi:10.1007/s11154-007-9063-z
24. Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T (2013) Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine. doi:10.1007/s12020-013-9981-3
25. Erdogan G, Erdogan MF, Emral R, Bastemir M, Sav H, Haznedaroglu D, Ustundag M, Kose R, Kamel N, Genc Y (2002) Iodine status and goiter prevalence in Turkey before mandatory iodization. J Endocrinol Invest 25(3):224-228 (Pubitemid 34295876)
26. Erdogan MF, Agbaht K, Altunsu T, Ozbas S, Yucesan F, Tezel B, Sargin C, Ilbeg I, Artik N, Kose R, Erdogan G (2009) Current iodine status in Turkey. J Endocrinol Invest 32(7):617-622. doi:10.3275/6379
27. Erdogan G, Erdogan MF, Delange F, Sav H, Gullu S, Kamel N (2000) Moderate to severe iodine deficiency in three endemic goitre areas from the Black Sea region and the capital of Turkey. Eur J Epidemiol 16(12):1131-1134 (Pubitemid 32645837)
28. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, degli Uberti EC, Pezzino V (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63(2):161-167. doi:10.1111/j.1365-2265.2005.02316.x (Pubitemid 41097984)
29. Kurimoto M, Fukuda I, Hizuka N, Takano K (2008) The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J 55(1):67-71. doi:10.1507/endocrj.K07E-010 (Pubitemid 351520181)
30. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, Dos Santos Faria M (2013) Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16(1):109-114. doi:10.1007/s11102-012-0383-y
31. Clero E, Doyon F, Chungue V, Rachedi F, Boissin JL, Sebbag J, Shan L, Bost-Bezeaud F, Petitdidier P, Dewailly E, Rubino C, de Vathaire F (2012) Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid 22(4):422-429. doi:10.1089/thy.2011.0173
32. Ozdemir D, Dagdelen S, Kiratli P, Tuncel M, Erbas B, Erbas T (2012) Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster. Minerva Endocrinol 37(3):267-274
33. Tramontano D, Cushing GW, Moses AC, Ingbar SH (1986) Insulinlike growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 119(2):940-942 (Pubitemid 16048857)
34. Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC, Giordano G (1989) Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 68(3):621-626 (Pubitemid 19081438)
35. Onoda N, Ohmura E, Tsushima T, Ohba Y, Emoto N, Isozaki O, Sato Y, Shizume K, Demura H (1992) Autocrine role of insulinlike growth factor (IGF)-I in a human thyroid cancer cell line. Eur J Cancer 28A(11):1904-1909
36. Nabarro JD (1987) Acromegaly. Clin Endocrinol 26(4):481-512
37. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European journal of endocrinology/European Federation of Endocrine Societies 151(4):439-446
38. Emerman JT, Leahy M, Gout PW, Bruchovsky N (1985) Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17(8):421-424. doi:10.1055/s-2007-1013563 (Pubitemid 15043142)
39. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A(4):492-497 (Pubitemid 23036292)
40. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113):1393-1396. doi:10.1016/S0140-6736(97)10384-1 (Pubitemid 28209997)
41. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79(2):202-211 (Pubitemid 28201694)
42. Pollak MN (1998) Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47(3):209-217
43. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr (1991) Acromegaly and gastrointestinal cancer. Cancer 68(8):1673-1677
44. Bogazzi F, Russo D, Locci MT, Chifenti B, Ultimieri F, Raggi F, Cosci C, Sardella C, Costa A, Gasperi M, Bartalena L, Martino E (2005) Apoptosis is reduced in the colonic mucosa of patients with acromegaly. Clin Endocrinol 63(6):683-688. doi:10.1111/j.1365-2265.2005.02405.x (Pubitemid 41779643)
45. Dutta P, Bhansali A, Vaiphei K, Dutta U, Ravi Kumar P, Masoodi S, Mukherjee KK, Varma A, Kochhar R (2012) Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis? Pituitary 15(2):166-173. doi:10.1007/s11102-011-0300-9
46. Bustin SA, Dorudi S, Phillips SM, Feakins RM, Jenkins PJ (2002) Local expression of insulin-like growth factor-I affects angiogenesis in colorectal cancer. Tumour Biol 23(3):130-138. doi:10.1159/000064029 (Pubitemid 44858304)